Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi posts positive results for drug in chronic sinusitis
Yahoo/Reuters
Tuesday, September 30, 2014 - 8:41am
tags:
Sanofi, chronic sinusitis, Regeneron, dupilumab
Medical Devices Lack Safety Evidence, Study Finds
WSJ Online
Tuesday, September 30, 2014 - 8:39am
tags:
devices, safety
Medtronic-Covidien Megamerger May Fall Apart
Bidness Etc.
Tuesday, September 30, 2014 - 8:37am
tags:
Medtronic, Covidien, M&A, devices
Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign targeting women
Yahoo/AP
Tuesday, September 30, 2014 - 8:36am
tags:
Pfizer, Viagra, drug ads
AbbVie Tell Shire Employees: The Merger Will Go On
WSJ Online
Monday, September 29, 2014 - 8:14pm
tags:
AbbVie, Shire, M&A
FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Monday, September 29, 2014 - 2:00pm
tags:
FDA, Xolair, asthma, Roche, Genentech
Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien
Mass Device
Monday, September 29, 2014 - 1:55pm
tags:
pSivida, Alimera, FDA, devices, Iluvien, diabetic macular edema
Is Ambit Biosciences Getting Enough in Its Buyout?
Yahoo/24-7 Wall St
Monday, September 29, 2014 - 1:53pm
tags:
M&A, Ambit Biosciences, Daiichi Sankyo
Five Reasons Celgene Could Gain 20%
Barron's
Monday, September 29, 2014 - 1:52pm
tags:
Celgene, Actavis
Clovis Shares Higher on Improved Outlook for Lung Cancer Drug
TheStreet.com
Monday, September 29, 2014 - 1:50pm
tags:
Clovis Oncology, lung cancer, AZD9291, rociletinib
MicroBiome Therapeutics' Drug May Limit Metformin Side Effects
Drug Discovery and Development
Monday, September 29, 2014 - 1:18pm
tags:
MicroBiome Therapeutics, diabetes, metformin, NM505
Novo Nordisk Establishes New Obesity Research Unit
Drug Discovery and Development
Monday, September 29, 2014 - 1:17pm
tags:
Novo Nordisk, obesity, R&D
Pharma Events To Watch Out For This Week
Bidness Etc.
Monday, September 29, 2014 - 1:15pm
tags:
Salix, Progenics, Relistor, AASLD, Merck, Gilead Sciences, AbbVie, Intercept Pharma
AstraZeneca Might Outperform Merck, Bristol-Myers In Cancer Therapy Market
Bidness Etc.
Monday, September 29, 2014 - 10:31am
tags:
Merck, Bristol-Myers Squibb, AstraZeneca, MEDI4736, cancer immunotherapy
Tonix Pharma's pain drug fails mid-stage study
Yahoo/Reuters
Monday, September 29, 2014 - 10:23am
tags:
Tonix Pharmaceuticals, fibromyalgia, TNX-102
Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
TheStreet.com
Monday, September 29, 2014 - 10:16am
tags:
Seattle Genetics, Adcetris, Hodgkin's lymphoma
3 Likely Biotech Buyout Candidates
24/7 Wall St
Monday, September 29, 2014 - 9:27am
tags:
biotech, M&A, Alkermes, Jazz Pharmaceuticals, Salix
Amag Pharma buys women's health company Lumara for $675 mln
Yahoo/Reuters
Monday, September 29, 2014 - 9:26am
tags:
Amag Pharmaceuticals, M&A, Lumara, Women's Health
Allergan Board of Directors Issues Statement Indicating Valeant Bid is Still Not Being Considered
Yahoo
Monday, September 29, 2014 - 9:00am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Roche's Perjeta increases survival in late-stage breast cancer study
First Word Pharma
Monday, September 29, 2014 - 8:53am
tags:
Roche, Perjeta, breast cancer, Herceptin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.